• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results

    2/23/26 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025.

    Fourth Quarter 2025 Highlights:

    • Net Service Revenues Increase 25.6% to $373.1 Million
    • Net Income of $29.8 Million, or $1.61 per Diluted Share
    • Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77
    • Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million
    • Cash Flow from Operations of $18.8 Million

    Overview

    Net service revenues were $373.1 million for the fourth quarter of 2025, a 25.6% increase compared with $297.1 million for the fourth quarter of 2024. Net income was $29.8 million for the fourth quarter of 2025 compared with $19.5 million for the fourth quarter of 2024, while net income per diluted share was $1.61 compared with $1.07 for the same period a year ago. Adjusted EBITDA increased 33.3% to $50.3 million for the fourth quarter of 2025 from $37.8 million for the fourth quarter of 2024. Adjusted net income was $32.6 million for the fourth quarter of 2025 compared with $25.2 million for the prior-year period, while adjusted net income per diluted share was $1.77 compared with $1.38 for the fourth quarter of 2024. Adjusted net income per diluted share for the fourth quarter of 2025 excludes the impact of accounts receivable settlements related to divested New York operations of $(0.07), acquisition expenses of $0.05 and stock-based compensation expense of $0.18. (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

    For the full year 2025, net service revenues increased 23.2% to $1.42 billion from $1.15 billion for the prior-year period. Net income was $95.9 million for 2025 compared with $73.6 million for 2024, and net income per diluted share was $5.22 compared with $4.23 per diluted share. Adjusted EBITDA increased 28.3% to $180.0 million for 2025 from $140.3 million for 2024. Adjusted net income was $114.7 million for 2025 compared with $91.4 million for 2024, while adjusted net income per diluted share was $6.23 compared with $5.26 for the prior-year period.

    Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, "Our fourth quarter results marked a strong finish to a successful year of growth and progress for Addus. Net service revenues increased 25.6% and adjusted EBITDA was up 33.3% over the fourth quarter of 2024. For the full year, we achieved a new annual record of $1.4 billion in net service revenues, an increase of 23.2% compared with 2024. Continued strong demand has supported this impressive growth as an increasing number of consumers and payers benefit from the value and cost efficiency offered by our home-based care services. With solid execution, our team has done an outstanding job meeting this demand with the ability to leverage our scale and proven operating model across the care continuum. We have also benefitted from continued favorable and stable hiring trends, which support our business, especially in our personal care segment. We are fortunate to have a team of capable and dedicated caregivers who provide outstanding care as we respond to the needs of a growing number of patients and families across the markets we serve.

    "Our personal care business has been the key driver of our growth and accounted for 76.6% of our revenues for the fourth quarter. The 6.3% organic revenue growth in our personal care business was supported by strong volumes as well as higher rates in certain key markets compared with the same period last year. These results also include the personal care operations of Del Cielo Home Care Services ("Del Cielo"), which we acquired on October 1, 2025.

    "We are pleased with the funding support from many of the states where we operate, including a recent 9.9% rate increase in Texas that was effective September 1, 2025. With the addition of Gentiva's personal care operations in December 2024, and more recently Del Cielo, Texas is now our second largest personal care market, so this increase will have a significant positive impact on our business going forward. In addition, the State of Illinois, our largest personal care market, announced an increase of 3.9% beginning January 1, 2026.

    "We are pleased with the positive trends in our hospice care business, which accounted for 18.8% of our revenue in the fourth quarter. The operational improvements we have made over the past year resulted in a solid 16.0% organic revenue growth supported by year-over-year increases in admissions, average daily census, and revenue per patient day. Our home health services accounted for 4.6% of fourth quarter revenue. While this represents our smallest business segment, we continue to believe our home health operations provide an important clinical partner to our personal care and hospice care segments, allowing us to further our goal of providing all three levels of care in select markets," said Allison.

    Cash and Liquidity

    As of December 31, 2025, the Company had cash of $81.6 million and bank debt of $124.3 million, with capacity and availability under its revolving credit facility of $650.0 million and $517.7 million, respectively. Net cash provided by operating activities was $18.8 million for the fourth quarter of 2025 and $111.5 million for 2025.

    Allison added, "We have continued to use our strong cash flow from operations in 2025 to pay down debt, allowing us greater flexibility in our capital allocation strategy. Acquisitions remain an integral part of our overall growth strategy, and Addus has achieved a solid record of deriving value from our acquired operations, including three acquisitions completed in 2025. Going forward, our development team will continue to assess both clinical and non-clinical operations to increase the density and geographic coverage in strategic markets. We also see important synergies in offering multiple elements of the care continuum as we build scale and extend our market reach. We are optimistic that we will see additional acquisition opportunities in 2026. While our priority is to deploy our capital for acquisitions, we also continue to invest in our business, adding technologies that support our operations and enhance the work of our caregivers.

    Looking Ahead

    "We are extremely proud of the important work Addus is doing to address a vital need for quality, compassionate care for more patients and families in their preferred home setting. We believe we offer a strong value proposition that meets the growing demand for home-based care. Our favorable results for 2025 affirm our strategic priorities, and we will continue to extend our market reach through both organic growth and acquisitions in the year ahead. We recognize the success of our operations and continued growth reflect the hard work and dedication of the caregivers who are the face of Addus, and we are grateful for the outstanding care and support they provide every day. Working together, we look forward to the opportunities ahead for Addus in 2026," said Allison.

    Non-GAAP Financial Measures

    The information provided in this release includes adjusted net income, adjusted EBITDA, adjusted net income per diluted share and adjusted net service revenue, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition expense, stock-based compensation expense, restructuring and other non-recurring costs, the gain or loss on the sale of assets, the impairment of operating lease assets, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. The Company defines adjusted EBITDA as earnings before net interest expense, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructuring and other non-recurring costs, the gain or loss on the sale of assets, the impairment of operating lease assets, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. The Company defines adjusted net income per diluted share as net income per share, adjusted for acquisition expense, stock-based compensation expense, restructuring and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business operations among periods, and to facilitate comparison with the results of the Company's peers.

    Conference Call

    Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on March 3, 2026, by dialing (855) 669-9658 (international dial-in number is (412) 317-0088) and entering pass code 4057470.

    A live broadcast of Addus HomeCare's conference call will be available under the Investor Relations section of the Company's website: www.addus.com. An online replay will also be available on the Company's website for one month, beginning approximately two hours following the conclusion of the live broadcast.

    Forward-Looking Statements

    Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as "preliminary," "continue," "expect," and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare's relationships with referral sources, increased competition for Addus HomeCare's services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 25, 2025, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

    About Addus HomeCare

    Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare's consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare's payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,500 patients and consumers through 262 locations across 23 states. For more information, please visit www.addus.com.

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Condensed Consolidated Statements of Income
    (amounts and shares in thousands, except per share data)
    (Unaudited)
       

    For the Three Months

     For the Twelve Months

    Income Statement Information:   Ended December 31, Ended December 31,
     

    2025

    2024

    2025

    2024

       
    Net service revenues  

    $

    373,078

     

    $

    297,144

     

    $

    1,422,530

     

    $

    1,154,599

     

    Cost of service revenues  

     

    249,473

     

     

    195,662

     

     

    960,656

     

     

    779,578

     

       
    Gross profit  

     

    123,605

     

     

    101,482

     

     

    461,874

     

     

    375,021

     

     

     

    33.1

    %

     

    34.2

    %

     

    32.5

    %

     

    32.5

    %

    General and administrative expenses  

     

    77,180

     

     

    71,356

     

     

    306,847

     

     

    258,800

     

    Depreciation and amortization  

     

    4,148

     

     

    3,214

     

     

    16,412

     

     

    13,530

     

    Total operating expenses  

     

    81,328

     

     

    74,570

     

     

    323,259

     

     

    272,330

     

       
    Operating income  

     

    42,277

     

     

    26,912

     

     

    138,615

     

     

    102,691

     

       
    Total interest expense, net  

     

    2,129

     

     

    698

     

     

    11,170

     

     

    3,338

     

       
    Income before income taxes  

     

    40,148

     

     

    26,214

     

     

    127,445

     

     

    99,353

     

    Income tax expense  

     

    10,366

     

     

    6,688

     

     

    31,535

     

     

    25,755

     

       
    Net income  

    $

    29,782

     

    $

    19,526

     

    $

    95,910

     

    $

    73,598

     

       
    Net income per diluted share:  

    $

    1.61

     

    $

    1.07

     

    $

    5.22

     

    $

    4.23

     

       
       
    Weighted average number of common shares outstanding:  
    Diluted  

     

    18,447

     

     

    18,294

     

     

    18,391

     

     

    17,380

     

       
       
       
       

    For the Three Months

    For the Twelve Months

    Cash Flow Information:   Ended December 31, Ended December 31,
     

    2025

    2024

    2025

    2024

       
    Net cash provided by operating activities  

    $

    18,763

     

    $

    10,418

     

    $

    111,507

     

    $

    116,434

     

    Net cash (used in) investing activities  

     

    (10,056

    )

     

    (354,486

    )

     

    (32,500

    )

     

    (354,610

    )

    Net cash provided by (used in) financing activities  

     

    (29,008

    )

     

    220,127

     

     

    (96,301

    )

     

    272,296

     

       
    Net change in cash  

     

    (20,301

    )

     

    (123,941

    )

     

    (17,294

    )

     

    34,120

     

    Cash at the beginning of the period  

     

    101,918

     

     

    222,852

     

     

    98,911

     

     

    64,791

     

    Cash at the end of the period  

    $

    81,617

     

    $

    98,911

     

    $

    81,617

     

    $

    98,911

     

    Condensed Consolidated Balance Sheets
    (Amounts in thousands)
    (Unaudited)
       
       
       
      December 31,
     

    2025

    2024

       
    Assets  
       
    Current assets  
    Cash  

    $

    81,617

    $

    98,911

    Accounts receivable, net  

     

    151,695

     

    122,880

    Prepaid expenses and other current assets  

     

    36,179

     

    38,591

       
    Total current assets  

     

    269,491

     

    260,382

       
    Property and equipment, net  

     

    24,998

     

    24,703

       
    Other assets  
    Goodwill  

     

    996,696

     

    970,558

    Intangible assets, net  

     

    102,410

     

    109,643

    Operating lease assets  

     

    43,713

     

    47,348

    Total other assets  

     

    1,142,819

     

    1,127,549

       
    Total assets  

    $

    1,437,308

    $

    1,412,634

       
    Liabilities and stockholders' equity  
       
    Current liabilities  
    Accounts payable  

    $

    16,832

    $

    27,176

    Accrued payroll  

     

    65,941

     

    62,053

    Accrued expenses  

     

    28,191

     

    28,959

    Operating lease liabilities - current portion  

     

    13,144

     

    12,800

    Government stimulus advance  

     

    11,699

     

    11,239

    Accrued workers compensation  

     

    13,680

     

    13,644

    Total current liabilities  

     

    149,487

     

    155,871

       
    Long-term debt, less current portion, net of debt issuance costs  

     

    120,959

     

    218,443

    Long-term lease liability, less current portion  

     

    37,259

     

    41,883

    Deferred tax liabilities, net  

     

    44,065

     

    25,820

    Other long-term liabilities  

     

    235

     

    125

    Total long-term liabilities  

     

    202,518

     

    286,271

       
    Total liabilities  

     

    352,005

     

    442,142

       
    Total stockholders' equity  

     

    1,085,303

     

    970,492

       
    Total liabilities and stockholders' equity  

    $

    1,437,308

    $

    1,412,634

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Net Service Revenue by Segment
    (Amounts in thousands)
    (Unaudited)
       

    For the Three Months

    For the Twelve Months

     

    Ended December 31,

    Ended December 31,

     

    2025

    2024

    2025

    2024

    Net Service Revenues by Segment  
       
    Personal Care  

    $

    285,976

    $

    220,328

    $

    1,089,215

    $

    856,581

    Hospice  

     

    70,002

     

    58,989

     

    262,542

     

    228,191

    Home Health  

     

    17,100

     

    17,827

     

    70,773

     

    69,827

    Total Revenue  

    $

    373,078

    $

    297,144

    $

    1,422,530

    $

    1,154,599

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Key Statistical and Financial Data (Unaudited)
             

    For the Three Months

    For the Twelve Months

     
      Ended December 31,   Ended December 31,
     

    2025

     

    2024

     

    2025

     

    2024

             
             
    Personal Care        
             
    States served at period end  

     

    -

     

     

     

    -

     

     

     

    23

     

     

     

    23

     

    Locations at period end  

     

    -

     

     

     

    -

     

     

     

    201

     

     

     

    196

     

    Average billable census - same store (1)  

     

    35,927

     

     

     

    36,342

     

     

     

    35,996

     

     

     

    36,474

     

    Average billable census - acquisitions (2)  

     

    15,044

     

     

     

    14,581

     

     

     

    15,253

     

     

     

    14,581

     

    Average billable census - divestiture (3)  

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    964

     

    Average billable census total  

     

    50,971

     

     

     

    50,923

     

     

     

    51,249

     

     

     

    52,019

     

    Billable hours (in thousands)  

     

    11,055

     

     

     

    8,210

     

     

     

    42,670

     

     

     

    31,309

     

    Average billable hours per census per month (2)  

     

    72.3

     

     

     

    69.6

     

     

     

    70.1

     

     

     

    71.5

     

    Billable hours per business day  

     

    167,505

     

     

     

    124,397

     

     

     

    163,487

     

     

     

    119,498

     

    Revenues per billable hour  

    $

    25.70

     

     

    $

    26.40

     

     

    $

    25.48

     

     

    $

    27.21

     

    Organic growth        
    - Revenue  

     

    6.3

     

    %

     

     

    5.8

     

    %

     

     

    7.0

     

    %

     

     

    7.7

     

    %

             
    Hospice        
             
    Locations served at period end  

     

    -

     

     

     

    -

     

     

     

    39

     

     

     

    38

     

    Admissions  

     

    3,180

     

     

     

    3,095

     

     

     

    13,240

     

     

     

    12,866

     

    Average daily census  

     

    3,885

     

     

     

    3,472

     

     

     

    3,760

     

     

     

    3,461

     

    Average discharge length of stay  

     

    104.2

     

     

     

    97.9

     

     

     

    95.6

     

     

     

    94.1

     

    Patient days  

     

    357,380

     

     

     

    319,460

     

     

     

    1,369,425

     

     

     

    1,266,701

     

    Revenue per patient day  

    $

    193.46

     

     

    $

    185.95

     

     

    $

    191.06

     

     

    $

    181.08

     

    Organic growth        
    - Revenue  

     

    16.0

     

    %

     

     

    7.8

     

    %

     

     

    14.1

     

    %

     

     

    5.9

     

    %

    - Average daily census  

     

    11.5

     

    %

     

     

    2.7

     

    %

     

     

    8.2

     

    %

     

     

    1.3

     

    %

             
    Home Health        
             
    Locations served at period end  

     

    -

     

     

     

    -

     

     

     

    22

     

     

     

    24

     

    New Admissions  

     

    4,621

     

     

     

    4,365

     

     

     

    18,474

     

     

     

    18,622

     

    Recertifications  

     

    2,568

     

     

     

    3,249

     

     

     

    11,010

     

     

     

    13,047

     

    Total Volume  

     

    7,189

     

     

     

    7,614

     

     

     

    29,484

     

     

     

    31,669

     

    Visits  

     

    86,304

     

     

     

    99,803

     

     

     

    366,228

     

     

     

    422,516

     

    Organic growth        
    - Revenue  

     

    (7.4

    )

    %

     

     

    1.6

     

    %

     

     

    (3.6

    )

    %

     

     

    (3.1

    )

    %

    - New admissions  

     

    3.5

     

    %

     

     

    (6.2

    )

    %

     

     

    (2.2

    )

    %

     

     

    (3.0

    )

    %

    - Volume  

     

    (7.5

    )

    %

     

     

    (3.2

    )

    %

     

     

    (8.0

    )

    %

     

     

    (1.9

    )

    %

             
    Percentage of Revenues by Payor:        
             
    Personal Care        
             
    State, local and other governmental programs  

     

    49.9

     

    %

     

     

    54.2

     

    %

     

     

    50.8

     

    %

     

     

    53.3

     

    %

    Managed care organizations  

     

    47.3

     

     

     

    43.1

     

     

     

    46.0

     

     

     

    44.0

     

    Private duty  

     

    2.3

     

     

     

    2.0

     

     

     

    2.6

     

     

     

    1.8

     

    Commercial  

     

    0.4

     

     

     

    0.5

     

     

     

    0.5

     

     

     

    0.7

     

    Other  

     

    0.1

     

    %

     

     

    0.2

     

    %

     

     

    0.1

     

    %

     

     

    0.2

     

    %

             
    Hospice        
             
    Medicare  

     

    93.7

     

    %

     

     

    91.4

     

    %

     

     

    93.1

     

    %

     

     

    91.2

     

    %

    Commercial  

     

    2.9

     

     

     

    4.9

     

     

     

    3.3

     

     

     

    5.1

     

    Managed care organizations  

     

    2.7

     

     

     

    3.5

     

     

     

    3.1

     

     

     

    3.3

     

    Other  

     

    0.7

     

    %

     

     

    0.2

     

    %

     

     

    0.5

     

    %

     

     

    0.4

     

    %

             
    Home Health        
             
    Medicare  

     

    64.3

     

    %

     

     

    69.2

     

    %

     

     

    67.4

     

    %

     

     

    69.5

     

    %

    Managed care organizations  

     

    26.0

     

     

     

    24.2

     

     

     

    24.0

     

     

     

    25.2

     

    State, local and other governmental programs  

     

    6.5

     

     

     

    3.4

     

     

     

    5.7

     

     

     

    1.0

     

    Commercial  

     

    2.8

     

     

     

    2.9

     

     

     

    2.5

     

     

     

    3.9

     

    Other  

     

    0.4

     

    %

     

     

    0.3

     

    %

     

     

    0.4

     

    %

     

     

    0.4

     

    %

             
    (1) Exited sites would have reduced same store census for the three and twelve months ended December 31, 2024, by 64 and 65, respectively. Exited stores would have reduced same store census for the three and twelve months ended December 31, 2025, by 7 and 42, respectively.
     
    (2) The average billable census and average billable hours per census per month for the three and twelve months ended December 31, 2024, and December 31, 2025, were prorated for the date of the acquisition.
     
    (3) The average billable census associated with the divestiture of our New York business of 964 for the twelve months ended December 31, 2024, were reclassified out of same stores for comparability purposes.
    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Reconciliation of Non-GAAP Financial Measures
    (Amounts in thousands, except per share data)
    (Unaudited) (1)
       

    For the Three Months

    For the Twelve Months

      Ended December 31, Ended December 31,
     

    2025

    2024

    2025

    2024

    Reconciliation of Adjusted EBITDA to Net Income: (1)  
       
    Net income  

    $

    29,782

     

    $

    19,526

     

    $

    95,910

     

    $

    73,598

     

       
    Interest expense, net  

     

    2,129

     

     

    698

     

     

    11,170

     

     

    3,338

     

    (Gain) Loss on sale of assets  

     

    4

     

     

    (3,725

    )

     

    (2

    )

     

    (3,738

    )

    Income tax expense  

     

    10,366

     

     

    6,688

     

     

    31,535

     

     

    25,755

     

    Depreciation and amortization  

     

    4,148

     

     

    3,214

     

     

    16,412

     

     

    13,530

     

    Impact of lease impairment  

     

    -

     

     

    4,968

     

     

    -

     

     

    4,968

     

    Impact of New York retroactive rate increases  

     

    -

     

     

    (3,487

    )

     

    -

     

     

    (3,004

    )

    Impact of New York accounts receivable settlements  

     

    (1,864

    )

     

    -

     

     

    (1,864

    )

     

    -

     

    Acquisition expenses  

     

    1,227

     

     

    7,031

     

     

    8,899

     

     

    14,678

     

    Stock-based compensation expense  

     

    4,547

     

     

    2,858

     

     

    16,424

     

     

    11,165

     

    Restructure and other non-recurring costs  

     

    -

     

     

    -

     

     

    1,500

     

     

    -

     

    Adjusted EBITDA  

    $

    50,339

     

    $

    37,771

     

    $

    179,984

     

    $

    140,290

     

       
       
    Reconciliation of Adjusted Net Income to Net Income: (2)  
       
    Net income  

    $

    29,782

     

    $

    19,526

     

    $

    95,910

     

    $

    73,598

     

       
    (Gain) Loss on sale of assets  

     

    4

     

     

    (3,725

    )

     

    (2

    )

     

    (3,738

    )

    Impact of lease impairment  

     

    -

     

     

    4,968

     

     

    -

     

     

    4,968

     

    Impact of New York retroactive rate increases  

     

    -

     

     

    (3,487

    )

     

    -

     

     

    (3,004

    )

    Impact of New York accounts receivable settlements  

     

    (1,864

    )

     

    -

     

     

    (1,864

    )

     

    -

     

    Acquisition expenses  

     

    1,227

     

     

    7,031

     

     

    8,899

     

     

    14,678

     

    Stock-based compensation expense  

     

    4,547

     

     

    2,858

     

     

    16,424

     

     

    11,165

     

    Restructure and other non-recurring costs  

     

    -

     

     

    -

     

     

    1,500

     

     

    -

     

    Tax Effect  

     

    (1,072

    )

     

    (1,958

    )

     

    (6,175

    )

     

    (6,240

    )

       
    Adjusted Net Income  

    $

    32,624

     

    $

    25,213

     

    $

    114,692

     

    $

    91,427

     

       
       
    Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
       
    Net income per diluted share  

    $

    1.61

     

    $

    1.07

     

    $

    5.22

     

    $

    4.23

     

       
    (Gain) Loss on the sale of assets per diluted share  

     

    -

     

     

    (0.15

    )

     

    -

     

     

    (0.16

    )

    Impact of lease impairment per diluted share  

     

    -

     

     

    0.20

     

     

    -

     

     

    0.21

     

    Impact of New York retroactive rate increases per diluted share  

     

    -

     

     

    (0.14

    )

     

    -

     

     

    (0.13

    )

    Impact of New York accounts receivable settlements per diluted share  

     

    (0.07

    )

     

    -

     

     

    (0.08

    )

     

    -

     

    Acquisition expenses per diluted share  

     

    0.05

     

     

    0.29

     

     

    0.36

     

     

    0.63

     

    Restructure and other non-recurring costs per diluted share  

     

    -

     

     

    -

     

     

    0.06

     

     

    -

     

    Stock-based compensation expense per diluted share  

     

    0.18

     

     

    0.11

     

     

    0.67

     

     

    0.48

     

       
    Adjusted net income per diluted share  

    $

    1.77

     

    $

    1.38

     

    $

    6.23

     

    $

    5.26

     

       
    Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
       
    Net service revenues  

    $

    373,078

     

    $

    297,144

     

    $

    1,422,530

     

    $

    1,154,599

     

       
    Revenues associated with the closure of certain sites  

     

    (994

    )

     

    (4,779

    )

     

    (4,309

    )

     

    (76,706

    )

       
    Adjusted net service revenues  

    $

    372,084

     

    $

    292,365

     

    $

    1,418,221

     

    $

    1,077,893

     

       
    Footnotes:    
    (1) We define Adjusted EBITDA as earnings before net interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. Additionally, our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We believe that Adjusted EBITDA is useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business among periods, and to facilitate comparison with results of the Company's peers. Additionally, we believe that Adjusted EBITDA is a measure widely used by securities analysts, investors and others to evaluate the financial performance of other public companies. The financial results presented in accordance with U.S GAAP and a reconciliation of this non-GAAP measure included within our Annual Report on Form 10-K should be carefully evaluated.
     
    (2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain on the sale of assets, lease impairment, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
     
    (3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain on the sale of assets, lease impairment, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
     
    (4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260223140576/en/

    Brian W. Poff

    Executive Vice President, Chief Financial Officer

    Addus HomeCare Corporation

    (469) 535-8200

    [email protected]

    Dru Anderson

    FINN Partners

    (615) 324-7346

    [email protected]

    Get the next $ADUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    1/7/2026$135.00Buy
    Truist
    11/13/2025$120.00Market Perform
    BMO Capital Markets
    9/2/2025$145.00Buy
    UBS
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    More analyst ratings

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on Addus HomeCare with a new price target

    Truist initiated coverage of Addus HomeCare with a rating of Buy and set a new price target of $135.00

    1/7/26 9:08:42 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on Addus HomeCare with a new price target

    BMO Capital Markets initiated coverage of Addus HomeCare with a rating of Market Perform and set a new price target of $120.00

    11/13/25 9:11:54 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    UBS initiated coverage on Addus HomeCare with a new price target

    UBS initiated coverage of Addus HomeCare with a rating of Buy and set a new price target of $145.00

    9/2/25 8:34:27 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Addus HomeCare to Participate in Upcoming March Investor Conferences

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences: Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026. Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer will participate in a virtual presentation at 9:20 a.m. Eastern Time / 8:20 a.m. Central Time on Monday, March 16, 2026. KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026. Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer will participate in

    3/9/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare to Participate in the Raymond James & Associates 47th Annual Institutional Investors Conference

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that management will participate in the Raymond James & Associates 47th Annual Institutional Investors Conference, which takes place March 1 – 4, 2026, in Orlando, Florida. In connection with the conference, there will be a live broadcast and replay of the Company's presentation available under the Investor Relations section of the Company's website, www.addus.com, starting at 8:40 a.m. Eastern Time / 7:40 a.m. Central Time on Tuesday, March 3, 2026. An online replay will also be available on the Company's website for one month, beginning approximately one hour following the conclusion of the live

    2/24/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow from Operations of $18.8 Million Overview Net service revenues were $373.1 million for the fourth quarter of 2025, a 25.6% increase compared with $297.1 million for the fourth quarter of 2024. Net income was $29.

    2/23/26 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    SEC Filings

    View All

    Amendment: SEC Form 10-K/A filed by Addus HomeCare Corporation

    10-K/A - Addus HomeCare Corp (0001468328) (Filer)

    3/12/26 4:31:19 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form 10-K filed by Addus HomeCare Corporation

    10-K - Addus HomeCare Corp (0001468328) (Filer)

    2/24/26 4:31:22 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Addus HomeCare Corp (0001468328) (Filer)

    2/23/26 4:16:02 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CCO and Quality Officer Raines Monica sold $22,882 worth of shares (224 units at $102.15), decreasing direct ownership by 2% to 13,577 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    3/3/26 4:30:52 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    EVP, CCO and Quality Officer Raines Monica sold $69,828 worth of shares (656 units at $106.45), decreasing direct ownership by 5% to 13,801 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    2/26/26 4:34:10 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    EVP, Chief Development Officer Blessing Cliff Donald sold $56,148 worth of shares (527 units at $106.54), decreasing direct ownership by 4% to 12,361 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    2/26/26 4:33:34 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    View All

    Addus HomeCare Names Heather Dixon President and Chief Operating Officer

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon has been appointed President and Chief Operating Officer of Addus and is expected to join the Company in that role in mid-September. W. Bradley Bickham, the Company's current President and Chief Operating Officer, has been appointed advisor to the Chief Executive Officer upon Dixon joining and has agreed to serve in that role until his previously announced retirement in March 2026. Commenting on today's announcement, Dirk Allison, Chairman and Chief Executive Officer, stated, "We are excited to welcome Heather Dixon as our new President and Chief Operating Officer. Heather's exte

    8/7/25 8:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

    Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

    7/15/21 6:00:00 AM ET
    $AXNX
    $ADUS
    Medical/Dental Instruments
    Health Care
    Medical/Nursing Services

    Addus HomeCare Announces Retirement of Laurie Manning

    Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

    6/14/21 8:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Financials

    Live finance-specific insights

    View All

    Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow from Operations of $18.8 Million Overview Net service revenues were $373.1 million for the fourth quarter of 2025, a 25.6% increase compared with $297.1 million for the fourth quarter of 2024. Net income was $29.

    2/23/26 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available

    2/9/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Third Quarter 2025 Financial Results

    Expands in Texas with Acquisition of Personal Care Operations of Del Cielo Home Care Services Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or $1.24 per Diluted Share Adjusted Net Income per Diluted Share Increases 20.0% year-over-year to $1.56 Adjusted EBITDA Increases 31.6% year-over-year to $45.1 Million Cash Flow from Operations of $51.3 Million Completed Del Cielo acquisition on October 1, 2025 Overview Net service revenu

    11/3/25 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Addus HomeCare Corporation

    SC 13G - Addus HomeCare Corp (0001468328) (Subject)

    11/13/24 9:44:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/13/24 4:55:59 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    1/22/24 2:03:09 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care